Home » Topics » Disease categories and therapies » Immune

Immune
RSS

SP-600125 evokes suppression of primary T-cell inhibition in vitro

Oct. 24, 2005

New data on the immunomodulatory effects of FTY-720

Oct. 24, 2005

Osiris to begin phase II study of Prochymal for severe GVHD

Oct. 18, 2005

FDA issues health alert over Menactra

Oct. 13, 2005

Novel immunomodulatory agents claimed

Oct. 11, 2005

Cerus and The University of New Mexico to develop tularemia vaccine

Oct. 10, 2005

Innogenetics extends collaboration with IDM Pharma

Oct. 6, 2005

Five reports of Guillain-Barre syndrome following administration of Menactra

Oct. 5, 2005

Japanese National Institute of Infectious Diseases to study Ampligen

Oct. 5, 2005

LigoCyte receives NIH grant for intranasal anthrax vaccine

Oct. 5, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...